Literature DB >> 22541439

Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model.

Laure Verret1, Edward O Mann, Giao B Hang, Albert M I Barth, Inma Cobos, Kaitlyn Ho, Nino Devidze, Eliezer Masliah, Anatol C Kreitzer, Istvan Mody, Lennart Mucke, Jorge J Palop.   

Abstract

Alzheimer's disease (AD) results in cognitive decline and altered network activity, but the mechanisms are unknown. We studied human amyloid precursor protein (hAPP) transgenic mice, which simulate key aspects of AD. Electroencephalographic recordings in hAPP mice revealed spontaneous epileptiform discharges, indicating network hypersynchrony, primarily during reduced gamma oscillatory activity. Because this oscillatory rhythm is generated by inhibitory parvalbumin (PV) cells, network dysfunction in hAPP mice might arise from impaired PV cells. Supporting this hypothesis, hAPP mice and AD patients had decreased levels of the interneuron-specific and PV cell-predominant voltage-gated sodium channel subunit Nav1.1. Restoring Nav1.1 levels in hAPP mice by Nav1.1-BAC expression increased inhibitory synaptic activity and gamma oscillations and reduced hypersynchrony, memory deficits, and premature mortality. We conclude that reduced Nav1.1 levels and PV cell dysfunction critically contribute to abnormalities in oscillatory rhythms, network synchrony, and memory in hAPP mice and possibly in AD.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22541439      PMCID: PMC3375906          DOI: 10.1016/j.cell.2012.02.046

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  55 in total

1.  Refractory, life-threatening status epilepticus in a 3-year-old girl.

Authors:  Pasquale Striano; Salvatore Striano; Carlo Minetti; Federico Zara
Journal:  Lancet Neurol       Date:  2008-03       Impact factor: 44.182

2.  Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.

Authors:  Marc Aurel Busche; Gerhard Eichhoff; Helmuth Adelsberger; Dorothee Abramowski; Karl-Heinz Wiederhold; Christian Haass; Matthias Staufenbiel; Arthur Konnerth; Olga Garaschuk
Journal:  Science       Date:  2008-09-19       Impact factor: 47.728

Review 3.  Perisomatic inhibition.

Authors:  Tamás F Freund; István Katona
Journal:  Neuron       Date:  2007-10-04       Impact factor: 17.173

4.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

5.  Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy.

Authors:  Rimante Minkeviciene; Sylvain Rheims; Marton B Dobszay; Misha Zilberter; Jarmo Hartikainen; Lívia Fülöp; Botond Penke; Yuri Zilberter; Tibor Harkany; Asla Pitkänen; Heikki Tanila
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

6.  Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

Authors:  Jorge J Palop; Jeannie Chin; Erik D Roberson; Jun Wang; Myo T Thwin; Nga Bien-Ly; Jong Yoo; Kaitlyn O Ho; Gui-Qiu Yu; Anatol Kreitzer; Steven Finkbeiner; Jeffrey L Noebels; Lennart Mucke
Journal:  Neuron       Date:  2007-09-06       Impact factor: 17.173

Review 7.  Epilepsy and cognitive impairments in Alzheimer disease.

Authors:  Jorge J Palop; Lennart Mucke
Journal:  Arch Neurol       Date:  2009-02-09

8.  Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation.

Authors:  Ikuo Ogiwara; Hiroyuki Miyamoto; Noriyuki Morita; Nafiseh Atapour; Emi Mazaki; Ikuyo Inoue; Tamaki Takeuchi; Shigeyoshi Itohara; Yuchio Yanagawa; Kunihiko Obata; Teiichi Furuichi; Takao K Hensch; Kazuhiro Yamakawa
Journal:  J Neurosci       Date:  2007-05-30       Impact factor: 6.167

9.  Cell-type-dependent molecular composition of the axon initial segment.

Authors:  Andrea Lorincz; Zoltan Nusser
Journal:  J Neurosci       Date:  2008-12-31       Impact factor: 6.167

10.  Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.

Authors:  Irene H Cheng; Kimberly Scearce-Levie; Justin Legleiter; Jorge J Palop; Hilary Gerstein; Nga Bien-Ly; Jukka Puoliväli; Sylvain Lesné; Karen H Ashe; Paul J Muchowski; Lennart Mucke
Journal:  J Biol Chem       Date:  2007-06-04       Impact factor: 5.157

View more
  425 in total

Review 1.  Potential of GABA-ergic cell therapy for schizophrenia, neuropathic pain, and Alzheimer's and Parkinson's diseases.

Authors:  Ashok K Shetty; Adrian Bates
Journal:  Brain Res       Date:  2015-09-28       Impact factor: 3.252

Review 2.  [Mechanisms of Alzheimer's disease : Neuronal hyperactivity and hypoactivity as new therapeutic targets].

Authors:  M A Busche; M Staufenbiel; M Willem; C Haass; H Förstl
Journal:  Nervenarzt       Date:  2016-11       Impact factor: 1.214

3.  PAK inactivation impairs social recognition in 3xTg-AD Mice without increasing brain deposition of tau and Aβ.

Authors:  Dany Arsenault; Alexandre Dal-Pan; Cyntia Tremblay; David A Bennett; Matthieu J Guitton; Yves De Koninck; Susumu Tonegawa; Frédéric Calon
Journal:  J Neurosci       Date:  2013-06-26       Impact factor: 6.167

Review 4.  Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms.

Authors:  Jeannie Chin; Helen E Scharfman
Journal:  Epilepsy Behav       Date:  2013-01-13       Impact factor: 2.937

Review 5.  Ion channels in genetic and acquired forms of epilepsy.

Authors:  Holger Lerche; Mala Shah; Heinz Beck; Jeff Noebels; Dan Johnston; Angela Vincent
Journal:  J Physiol       Date:  2012-10-22       Impact factor: 5.182

6.  Nav1.1-Overexpressing Interneuron Transplants Restore Brain Rhythms and Cognition in a Mouse Model of Alzheimer's Disease.

Authors:  Magdalena Martinez-Losa; Tara E Tracy; Keran Ma; Laure Verret; Alexandra Clemente-Perez; Abdullah S Khan; Inma Cobos; Kaitlyn Ho; Li Gan; Lennart Mucke; Manuel Alvarez-Dolado; Jorge J Palop
Journal:  Neuron       Date:  2018-03-15       Impact factor: 17.173

7.  The E280A presenilin mutation reduces voltage-gated sodium channel levels in neuronal cells.

Authors:  Doo Yeon Kim; Mary H Wertz; Vivek Gautam; Carla D'Avanzo; Raja Bhattacharyya; Dora M Kovacs
Journal:  Neurodegener Dis       Date:  2013-11-05       Impact factor: 2.977

8.  Incidence and impact of subclinical epileptiform activity in Alzheimer's disease.

Authors:  Keith A Vossel; Kamalini G Ranasinghe; Alexander J Beagle; Danielle Mizuiri; Susanne M Honma; Anne F Dowling; Sonja M Darwish; Victoria Van Berlo; Deborah E Barnes; Mary Mantle; Anna M Karydas; Giovanni Coppola; Erik D Roberson; Bruce L Miller; Paul A Garcia; Heidi E Kirsch; Lennart Mucke; Srikantan S Nagarajan
Journal:  Ann Neurol       Date:  2016-11-07       Impact factor: 10.422

9.  High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease.

Authors:  Tommaso Nuzzo; Andrea Mancini; Mattia Miroballo; Alessia Casamassa; Anna Di Maio; Giorgia Donati; Giulia Sansone; Lorenzo Gaetani; Federico Paolini Paoletti; Andrea Isidori; Paolo Calabresi; Francesco Errico; Lucilla Parnetti; Alessandro Usiello
Journal:  Amino Acids       Date:  2021-02-22       Impact factor: 3.520

10.  Cognitive enhancing treatment with a PPARγ agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice.

Authors:  Miroslav N Nenov; Fernanda Laezza; Sigmund J Haidacher; Yingxin Zhao; Rovshan G Sadygov; Jonathan M Starkey; Heidi Spratt; Bruce A Luxon; Kelly T Dineley; Larry Denner
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.